The Goldman Sachs Group Cuts Zimmer Biomet (NYSE:ZBH) Price Target to $104.00
Zimmer Biomet (NYSE:ZBH – Free Report) had its price target reduced by The Goldman Sachs Group from $120.00 to $104.00 in a research note released on Tuesday,Benzinga reports. They currently have a neutral rating on the medical equipment provider’s stock. A number of other research analysts have also recently issued reports on the stock. JMP […]
Zimmer Biomet (NYSE:ZBH – Free Report) had its price target reduced by The Goldman Sachs Group from $120.00 to $104.00 in a research note released on Tuesday,Benzinga reports. They currently have a neutral rating on the medical equipment provider’s stock. A number of other research analysts have also recently issued reports on the stock. JMP […]
